IFP Advisors’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-23
| Closed | -$7 | – | 3610 |
|
|
2023
Q2 | $7 | Buy |
+23
| New | +$7 | ﹤0.01% | 3431 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 4842 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 4646 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 4501 |
|
|
2019
Q1 | $3K | Buy |
500
+60
| +14% | +$360 | ﹤0.01% | 2042 |
|
|
2018
Q4 | $1K | Hold |
440
| – | – | ﹤0.01% | 3379 |
|
|
2018
Q3 | $4K | Hold |
440
| – | – | ﹤0.01% | 3307 |
|
|
2018
Q2 | $4K | Sell |
440
-150
| -25% | -$1.36K | ﹤0.01% | 3361 |
|
|
2018
Q1 | $7K | Hold |
590
| – | – | ﹤0.01% | 3028 |
|
|
2017
Q4 | $7K | Sell |
590
-100
| -14% | -$1.19K | ﹤0.01% | 3025 |
|
|
2017
Q3 | $6K | Sell |
690
-415
| -38% | -$3.61K | ﹤0.01% | 3300 |
|
|
2017
Q2 | $19K | Buy |
1,105
+565
| +105% | +$9.72K | ﹤0.01% | 2602 |
|
|
2017
Q1 | $11K | Sell |
540
-3,360
| -86% | -$68.4K | ﹤0.01% | 2843 |
|
|
2016
Q4 | $61K | Buy |
3,900
+2,000
| +105% | +$31.3K | ﹤0.01% | 1751 |
|
|
2016
Q3 | $25K | Buy |
1,900
+1,300
| +217% | +$17.1K | ﹤0.01% | 2265 |
|
|
2016
Q2 | $4K | Buy |
600
+100
| +20% | +$667 | ﹤0.01% | 3271 |
|
|
2016
Q1 | $3K | Buy |
+500
| New | +$3K | ﹤0.01% | 2042 |
|